One Command Center.
A trillion possibilities for precision.
Our gut houses trillions of bacteria,70% of our immune cells, and 500 million neurons. This rich and diverse community of cells, otherwise known as the enteric signaling network, acts as a command center by transmitting information throughout the body that can affect our propensity for disease.
Precision Enteric Medicines™ (PEM™) Platform
With over 44,000 genes and hundreds of metabolites newly discovered by Kintai scientists, our expertise in chemistry, human biology, experimental medicine and artificial intelligence fuel our PEM™ discovery platform to rapidly identify and develop new medicines.
Newly discovered genes
GI tract localization of >19,000 protein families
Previously uncharacterized compounds
Robust and Diverse Pipeline
Through a multidisciplinary approach leveraging the interconnected biology of the microbiome, gut immune system, and enteric nervous system and their roles in human pathology, Kintai has an initial portfolio of more than 10 therapeutic programs targeting multiple indications, including autoimmunity, cancer and neurological disease.
The company is deploying creative and bright minds from academia and industry to apply cutting edge experimental medicine approaches to expedite development and increase probability of success in bringing revolutionary medicines to patients.